SIT Swedish Implant Technology AB (publ)Active
Key figures
Key figures
2025Balance structure
Summary of annual reports2024–2025
| 2024 | 2025 | |
|---|---|---|
| Sales revenue | 0 | 197 276 |
| Profit for the reporting year | −6 115 | −1 424 478 |
| Retained earnings of previous periods | — | — |
| Total assets | 5 583 739 | 4 983 421 |
| Total liabilities | 64 854 | 728 214 |
| Total equity | 5 518 885 | 4 255 207 |
| Employees | — | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: SIT Swedish Implant Technology AB (publ)
Overview
SIT Swedish Implant Technology AB (publ) (org. no. 559491-4367) is a limited company (AB). The company was registered in 2024 and has existed for 2 years. Registered seat: Göteborg. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).
Economy
Net sales in financial year 2025 were 197 276 kr. Financial year 2025 ended with a loss of 1 424 478 kr. At the end of financial year 2025, total assets were 4 983 421 kr and equity 4 255 207 kr (equity ratio 85,4 %).
Sources and freshness
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 5 people. Data as of 2026-11-09. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.